Nature's Sunshine Products (NASDAQ: NATR) reported Q1 EPS of $0.12, $0.08 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $111 million versus the consensus estimate of $111.9 million.

GUIDANCE:

Nature's Sunshine Products sees Q2 2024 revenue of $455-480 million, versus the consensus of $467.9 million. And adjusted EBITDA to range between $42 - $48 million.

For earnings history and earnings-related data on Nature's Sunshine Products (NATR) click here.